Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 21.27% of NBY shares are held by financial institutions. EXODUSPOINT CAPITAL MANAGEMENT, LP is the top corporate investor, holding 20.16K shares valued at $113.70K. A 0.07% stake in NovaBay Pharmaceuticals, Inc. is owned by the company. BANK OF NEW YORK MELLON CORP owns 25.8K shares valued at $145.51K, which translates its holding of 0.09% of the stake in the company.
Among the NBY insiders holding of 0.02% of the stake in company, PIONEER PHARMA (HONG KONG) CO LTD, 10 percent owner, holds the largest shares of 5.19M. PIONEER PHARMA (SINGAPORE) PTE. LTD., 10 percent owner, is the second largest NBY insider with ownership of 4.53M shares. FU JIAN PING, 10 percent owner, stands third with possession of 4M shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| PIONEER PHARMA (HONG KONG) CO LTD | 10 percent owner | 5.19M |
| PIONEER PHARMA (SINGAPORE) PTE. LTD. | 10 percent owner | 4.53M |
| FU JIAN PING | 10 percent owner | 4M |
| FRAMEWORK VENTURES IV L.P. | 10 percent owner | 2.7M |
| R01 FUND LP | 10 percent owner | 2.7M |
| KAZLEY MICHAEL JOHN | Chief Executive Officer | 2.7M |
| NAQU AREA PIONEER PHARMA CO., LTD. | 10 percent owner | 2M |
| POPLAR POINT CAPITAL PARTNERS LP | 10 percent owner | 1.02M |
| CHINA PIONEER PHARMA HOLDINGS LTD | 10 percent owner | 608.16K |
| TUFTS ROBERT R. | director | 319.91K |
| SIECZKAREK MARK M | director | 196.47K |
| KHOSROVI BEHZAD | VP Research and Development | 135.3K |
| JONES ANDREW D. | CFO | 127.46K |
| HALL JUSTIN | CEO, GC and Director | 83.17K |
| PAULSON THOMAS J | CFO | 68.21K |
| LAZAR DAVID E. | 10 percent owner | 39.93K |
| STROMAN DAVID W. | SVP, Ophthalmic Product Devt. | 23K |
| FREIMAN PAUL E. | director | 15.14K |
| NAJAFI RAMIN | Chief Executive Officer | 12K |
| MCPHERSON T. ALEX | director | 4.1K |
| LI XINZHOU | 10 percent owner | 0 |
| WU MIJIA | director | 0 |
| RALEIGH JASON PHILIP | Interim CFO and Treasurer | 0 |
| KUNIN AUDREY | Chief Product Officer | 0 |
| KUNIN JEFFREY | President, DERMAdoctor, LLC | 0 |
| WICKS TONY D.S. | director | 0 |
